More Orthocell Ltd news
Orthocell LtdASX: OCC

Positive CelGro Study Results in ACL Reconstruction

Feb 4, 2018 at 11:19 PM EST · Issued by Orthocell Ltd

Filed with ASX · Feb 4, 2018 at 11:19 PM EST

On 6ix: 6ix.com/news/positive-celgro-study-results-in-acl-reconstruction

Orthocell Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Orthocell Ltd on 6ix

Story so far

  • Orthocell Receives CE Mark for CelGroNov 9, 2017
  • Orthocell Granted CelGro Patent Protection in CanadaOct 16, 2017
  • Celgro Positive Safety and Performance in Human Hip StudySep 6, 2017

Earlier from Orthocell

  • Appendix 4C - quarterlyJan 31, 2018
  • Orthocell Granted Canadian Tendon Regeneration PatentJan 30, 2018
  • New Patent for Suture-Less Repair of Soft Tissue SecuredJan 17, 2018
  • 50% Patient Treatment Milestone in Human Nerve TrialJan 1, 2018
  • Orthocell Granted European Tendon Regeneration PatentDec 14, 2017

Later from Orthocell

  • New Cell Factory Patent Granted in the USFeb 21, 2018
  • Orthocell Appoints First Distributor in the EUApr 29, 2018
  • Orthocell Announces Successful Bone Repair Study ResultsApr 30, 2018
  • Orthocell Extends Distributor Network in the EUMay 7, 2018
  • 10th Patient Treatment Milestone in Human Tendon StudyMay 17, 2018
All Orthocell news releases↗

Follow Orthocell into a list and get an email when it puts out news.

Follow Orthocell
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer